[Pulmonary hypertension following use of fenfluramine for obesity].
Pulmonary hypertension was diagnosed in a 41-year-old woman after 16 months' use of fenfluramine as a treatment for obesity. Despite discontinuation, pulmonary pressure remained elevated. Drug-induced pulmonary hypertension is rare but has been reported relatively often after use of the sympathicomimetic agent aminorexfumarate, but also, although more rarely, of fenfluramine.
Maesen
B L
BL
St. Antonius Ziekenhuis, afd. Longziekten, Nieuwegein.
Snijder
R J
RJ
Stricker
B H
BH
D000328:Adult; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects* / Q000627:therapeutic use; D006334:Heart Function Tests; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy*; D011669:Pulmonary Wedge Pressure; D012129:Respiratory Function Tests
D005277:Fenfluramine
Pulmonale hypertensie na fenfluraminegebruik wegens overgewicht.